Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

RYTM holding history

Rhythm Pharmaceuticals, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RYTM overviewAll 13F holders of RYTMFull Q2 2026 holdings

Shares (Q2 2026)
1,020
Value
$113.3K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of RYTM by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,020$113.3K<0.1%−21−2.0%ReducedHolders
Q1 20261,041$90.5K<0.1%+88+9.2%AddedHolders
Q4 2025953$102.0K<0.1%+807+552.7%AddedHolders
Q3 2025146$14.7K<0.1%00.0%UnchangedHolders
Q2 2025146$9.23K<0.1%00.0%UnchangedHolders
Q1 2025146$7.73K<0.1%+5+3.5%AddedHolders
Q4 2024141$7.89K<0.1%00.0%UnchangedHolders
Q3 2024141$7.39K<0.1%00.0%UnchangedHolders
Q2 2024141$5.79K<0.1%+79+127.4%AddedHolders
Q1 202462$2.69K<0.1%00.0%UnchangedHolders
Q4 202362$2.85K<0.1%−48−43.6%ReducedHolders
Q3 2023110$2.52K<0.1%−953−89.7%ReducedHolders
Q2 20231,063$17.5K<0.1%+1,018+2,262.2%AddedHolders
Q1 202345$803<0.1%00.0%UnchangedHolders
Q4 202245$1.31K<0.1%00.0%UnchangedHolders
Q3 202245$1.00K<0.1%+45NewHolders
Q2 20220$00.0%−130−100.0%Sold outHolders
Q1 2022130$1.00K<0.1%−3,034−95.9%ReducedHolders
Q4 20213,164$32.0K<0.1%+3,068+3,195.8%AddedHolders
Q3 202196$1.00K<0.1%−40−29.4%ReducedHolders
Q2 2021136$3.00K<0.1%−358−72.5%ReducedHolders
Q1 2021494$11.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.